Fennec Pharmaceuticals (FENC) EBIT Margin (2020 - 2026)
Fennec Pharmaceuticals' EBIT Margin was 9.72% in Q2 2026, up 38.02 percentage points from -28.31% a year earlier.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) EBIT Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Fennec Pharmaceuticals' EBIT Margin was -6.95% through Jun 30, 2026, up 22.10 percentage points year-over-year; for FY2025, it came in at -14.07%, down 19.47 percentage points from FY2024.
- EBIT Margin shows a five-year change of +8928.43 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was 5.40% in FY2024 (+65.50 pp), -60.09% in FY2023 (+1216.84 pp) and -1276.94% in FY2022.
- The Q2 2026 figure marks the highest quarterly EBIT Margin since Q1 2024.
- Compared with a year earlier, EBIT Margin was higher in four of the last seven quarters, with an average year-over-year change of +4.28 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q1 2024 (a gain of 368.41 percentage points); the worst was Q1 2025 (a drop of 63.39 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Fennec Pharmaceuticals | 373.11 Mn | 254.42 Mn | 17.15 Mn | 9.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.72% |
| Dec 31, 2025 | -18.54% |
| Sep 30, 2025 | -1.52% |
| Jun 30, 2025 | -28.31% |
| Mar 31, 2025 | -9.23% |
| Dec 31, 2024 | -11.79% |
| Sep 30, 2024 | -74.59% |
| Jun 30, 2024 | -69.39% |
| Mar 31, 2024 | 54.16% |
| Dec 31, 2023 | -18.67% |
| Sep 30, 2023 | -15.61% |
| Jun 30, 2023 | -140.33% |
| Mar 31, 2023 | -314.25% |
| Dec 31, 2020 | -1,673.00% |
API Access
Fennec Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=FENC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "FENC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=FENC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();